Virax Biolabs supplier receives EUA from FDA for COVID-19 Rapid Antigen Test

Virax Biolabs announced that their supplier has received an Emergency Use Authorization from the U.S. FDA for their Over-the-Counter COVID-19 Rapid Antigen Test. The Tests are ready for sale in the U.S. by Virax. Additionally, another Point of Care Rapid Antigen test to be distributed by Virax is seeking an approval with Health Canada for Canadian distribution. The Tests have been eligible for sale in markets accepting the CE Mark since 2020.